Aura Biosciences, Inc. (AURA) › Shareholders' EquityAura Biosciences, Inc. (AURA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$87.41M2020: -$108.71M2021: $152.31M2022: $195.58M2023: $225.85M2024: $151.97M2025: $136.91M$136.91M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$136.91M-9.9%2024$151.97M-32.7%2023$225.85M+15.5%2022$195.58M+28.4%2021$152.31M+240.1%2020-$108.71M-24.4%2019-$87.41M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share